What's in Acrotech Biopharma Inc.'s pipeline?

Acrotech Biopharma Inc. has 9 drugs in our index: 2 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 3 in Phase 1.

Which companies overlap with Acrotech Biopharma Inc.'s portfolio?

Top competitors by shared drug class: AstraZeneca, ANI Pharmaceuticals, Asan Medical Center, Advenchen Laboratories Nanjing Ltd., Allergan.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/acrotech-biopharma-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Acrotech Biopharma Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acrotech Biopharma Inc. pipeline: 2 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 1 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
COP	COP	marketed	Corticosteroid	Glucocorticoid receptor	Respiratory
Vitamin B12	Vitamin B12	marketed	Vitamin / Essential nutrient	Methionine synthase, methylmalonyl-CoA mutase	Hematology / Neurology
Belinostat Injection	Belinostat Injection	phase 3	Histone deacetylase (HDAC) inhibitor	Histone deacetylase (HDAC)	Oncology

Therapeutic area mix

Oncology · 3
Hematology / Neurology · 1
Other · 1
Respiratory · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 2 shared drug classes
ANI Pharmaceuticals · 1 shared drug class
Asan Medical Center · 1 shared drug class
Advenchen Laboratories Nanjing Ltd. · 1 shared drug class
Allergan · 1 shared drug class
Aramis Biosciences, Inc. · 1 shared drug class
AbbVie · 1 shared drug class
AIDS Malignancy Consortium · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Acrotech Biopharma Inc.:

Cite this brief

Drug Landscape (2026). Acrotech Biopharma Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/acrotech-biopharma-inc. Accessed 2026-05-16.